In Uncategorized Posted
Two Postdoc positions at University of Cape Town
The University of Cape Town (UCT) has two Postdoc vacancies: Postdoctoral Fellowship in Tuberculosis Immunology Postdoctoral Fellowship in Single Cell Clinical Immunology
The University of Cape Town (UCT) has two Postdoc vacancies: Postdoctoral Fellowship in Tuberculosis Immunology Postdoctoral Fellowship in Single Cell Clinical Immunology
From 10-12 May 2022, the Kick-off Meeting (KoM) of the MTBVAC phase III clinical trial EDCTP co-funded project was held in Baiona, Spain. With the only licensed TB vaccine, Bacillus [...]
Vaccine Development Services: Deadline May 31st, 2022 Developing a vaccine is a time-consuming and complex process, requiring a combination of specialized skills and technical capacities not [...]
To enhance the coordination and collaboration between the EDCTP-funded TB vaccine research projects, the four TB vaccine research projects meet annually to exchange knowledge and experiences on [...]
Stop TB Partnership Announcement – 01 April 2022 Launched 2nd Global Online Consultation to Develop Global Plan to End TB 2023 – 2030
Tuberculosis (TB) remains one of the deadliest infectious diseases in the world, killing 1.5 million each year. Around 10 million people develop TB disease annually and 4,000 die of TB every day. [...]
Recommendations of TBVI for the European Commission call for evidence on: Antimicrobial resistance – Recommendation for greater action
To eliminate TB globally, new effective and affordable vaccines are needed. Please read the roadmap that lists the actions needed to accelerate TB R&.
Biofabri and Bharat Biotech partner to develop, manufacture and distribute a novel TB vaccine, MTBVAC
Joint press release Global Forum in Toulouse.
Runderweg 6
8219 PK Lelystad
The Netherlands
Email: info@tbvi.eu
Phone: +31 320 277 550